11.66
price down icon3.08%   -0.37
after-market After Hours: 11.65 -0.010 -0.09%
loading
CorMedix Inc stock is traded at $11.66, with a volume of 4.58M. It is down -3.08% in the last 24 hours and up +66.57% over the past month. CorMedix, Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its primary focus is on the development of its lead product candidate, Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as dialysis, critical/intensive care, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix, Inc. was founded in 2006 and is based in Berkeley Heights, New Jersey.
See More
Previous Close:
$12.03
Open:
$12.11
24h Volume:
4.58M
Relative Volume:
2.69
Market Cap:
$636.06M
Revenue:
$65,400
Net Income/Loss:
$-46.34M
P/E Ratio:
-12.67
EPS:
-0.92
Net Cash Flow:
$-38.74M
1W Performance:
+24.31%
1M Performance:
+66.57%
6M Performance:
+0.52%
1Y Performance:
+115.53%
1-Day Range:
Value
$11.42
$12.31
1-Week Range:
Value
$8.72
$12.31
52-Week Range:
Value
$3.61
$13.85

CorMedix Inc Stock (CRMD) Company Profile

Name
Name
CorMedix Inc
Name
Phone
908-517-9500
Name
Address
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
Name
Employee
14
Name
Twitter
Name
Next Earnings Date
2025-03-25
Name
Latest SEC Filings
Name
CRMD's Discussions on Twitter

Compare CRMD with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CRMD
CorMedix Inc
11.66 636.06M 65,400 -46.34M -38.74M -0.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
424.99 128.84B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
527.78 65.38B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
549.65 39.67B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.15 33.82B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ONC
Beigene Ltd Adr
231.99 27.60B 3.81B -644.79M -669.77M -6.24

CorMedix Inc Stock (CRMD) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-07-25 Initiated Leerink Partners Outperform
Jan-13-25 Initiated D. Boral Capital Buy
Aug-26-24 Initiated Rodman & Renshaw Buy
Aug-10-23 Initiated RBC Capital Mkts Outperform
Feb-17-21 Initiated Needham Buy
Sep-29-20 Initiated JMP Securities Mkt Outperform
Sep-21-20 Initiated Truist Buy
Dec-18-19 Initiated B. Riley FBR Buy
Mar-26-19 Reiterated H.C. Wainwright Buy
Dec-06-18 Initiated ROTH Capital Buy
Sep-25-17 Reiterated H.C. Wainwright Buy
Aug-10-17 Reiterated Rodman & Renshaw Buy
May-05-17 Reiterated Rodman & Renshaw Buy
Nov-11-16 Reiterated FBR & Co. Outperform
Mar-17-16 Reiterated FBR Capital Outperform
Mar-03-16 Initiated FBR Capital Outperform
Nov-16-15 Reiterated ROTH Capital Neutral
Oct-29-15 Reiterated ROTH Capital Neutral
May-06-15 Downgrade ROTH Capital Buy → Neutral
Dec-08-14 Reiterated ROTH Capital Buy
Oct-03-11 Downgrade Maxim Group Buy → Hold
View All

CorMedix Inc Stock (CRMD) Latest News

pulisher
May 09, 2025

Surging Earnings Estimates Signal Upside for CorMedix (CRMD) Stock - Nasdaq

May 09, 2025
pulisher
May 09, 2025

Market Highlights: CorMedix Inc (CRMD) Ends on a High Note at 12.03 - DWinneX

May 09, 2025
pulisher
May 09, 2025

CorMedix Inc. (CRMD): Among Billionaire Paul Singer’s Stock Picks with Huge Upside Potential - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

Cormedix anticipates Q2 revenue at high end of $23M-$31M range with inpatient growth accelerating - MSN

May 09, 2025
pulisher
May 08, 2025

CorMedix at Citizens JMP: Strategic Growth and Market Expansion - Investing.com

May 08, 2025
pulisher
May 08, 2025

CorMedix Inc. (NASDAQ:CRMD) Q1 2025 Earnings Call Transcript - Insider Monkey

May 08, 2025
pulisher
May 08, 2025

Analysts Just Shipped A Substantial Upgrade To Their CorMedix Inc. (NASDAQ:CRMD) Estimates - Yahoo Finance

May 08, 2025
pulisher
May 07, 2025

(CRMD) Investment Analysis - news.stocktradersdaily.com

May 07, 2025
pulisher
May 07, 2025

CorMedix stock rises after earnings, revenue beat - MSN

May 07, 2025
pulisher
May 07, 2025

Earnings call transcript: CorMedix Q1 2025 results beat expectations, stock rises - Investing.com Nigeria

May 07, 2025
pulisher
May 07, 2025

Cormedix Inc (CRMD) Q1 2025 Earnings Call Highlights: Record Profitability and Strategic Growth ... By GuruFocus - Investing.com Canada

May 07, 2025
pulisher
May 07, 2025

CorMedix Inc. Reports Strong Q1 2025 Results - TipRanks

May 07, 2025
pulisher
May 07, 2025

Earnings call transcript: CorMedix Q1 2025 results beat expectations, stock rises By Investing.com - Investing.com South Africa

May 07, 2025
pulisher
May 06, 2025

CorMedix: Q1 Earnings Snapshot - Norwalk Hour

May 06, 2025
pulisher
May 06, 2025

CorMedix Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 06, 2025
pulisher
May 06, 2025

CorMedix Inc. Reports Strong Q1 Earnings and Positive Outlook - TipRanks

May 06, 2025
pulisher
May 06, 2025

CRMD Price Target Increased as Positive Momentum Builds | CRMD S - GuruFocus

May 06, 2025
pulisher
May 06, 2025

CorMedix Shares Soar After Q1 Earnings, Revenue Beat Consensus - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025 - The Globe and Mail

May 06, 2025
pulisher
May 06, 2025

Cormedix Inc (CRMD) Q1 2025 Earnings: EPS of $0.32 Beats Estimat - GuruFocus

May 06, 2025
pulisher
May 06, 2025

CorMedix (CRMD) Surpasses Revenue and EPS Expectations in Q1 - GuruFocus

May 06, 2025
pulisher
May 06, 2025

CRMD Price Target Increased as Positive Momentum Builds | CRMD Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

CorMedix Inc. Revises Sales Guidance for the First Half of 2025 - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

CorMedix (CRMD) Surges on Strong Q1 Earnings - GuruFocus

May 06, 2025
pulisher
May 06, 2025

CorMedix Inc (NASDAQ: CRMD): Hidden Gems In A Time Of Volatility - Stocksregister

May 06, 2025
pulisher
May 06, 2025

CRMD Stock Rating and Price Target Maintained by Analyst | CRMD - GuruFocus

May 06, 2025
pulisher
May 06, 2025

CorMedix Q1 Earnings Trump Estimates: Retail’s Overjoyed - Asianet Newsable

May 06, 2025
pulisher
May 06, 2025

CorMedix stock rises as Q1 earnings and revenue surpass estimates By Investing.com - Investing.com India

May 06, 2025
pulisher
May 06, 2025

CorMedix stock rises as Q1 earnings and revenue surpass estimates - Investing.com Australia

May 06, 2025
pulisher
May 06, 2025

CorMedix (CRMD) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance

May 06, 2025
pulisher
May 06, 2025

CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 06, 2025
pulisher
May 06, 2025

CorMedix Inc. Reports Q1 2025 Financial Results: $39.1 Million in Net Revenue and Positive Adjusted EBITDA of $23.6 Million - Nasdaq

May 06, 2025
pulisher
May 05, 2025

Cormedix Inc (CRMD) Q1 2025: Everything You Need To Know Ahead O - GuruFocus

May 05, 2025
pulisher
May 02, 2025

Market Momentum Report: CorMedix Inc (CRMD)’s Positive Close at 9.65 - DWinneX

May 02, 2025
pulisher
May 02, 2025

CorMedix Inc expected to post earnings of 25 cents a shareEarnings Preview - TradingView

May 02, 2025
pulisher
May 02, 2025

Investors in cash trouble should check out CorMedix Inc (CRMD) - Sete News

May 02, 2025
pulisher
Apr 30, 2025

The CorMedix Inc (CRMD) had a good session last reading, didn’t it? - uspostnews.com

Apr 30, 2025
pulisher
Apr 30, 2025

Investing in CorMedix Inc (CRMD): What You Must Know - knoxdaily.com

Apr 30, 2025
pulisher
Apr 29, 2025

CorMedix Inc. to Announce First Quarter 2025 Financial Results and Corporate Update on May 6, 2025 - Nasdaq

Apr 29, 2025
pulisher
Apr 29, 2025

Cormedix To Report First Quarter 2025 Financial Results - marketscreener.com

Apr 29, 2025
pulisher
Apr 28, 2025

Form DEFA14A CorMedix Inc. - StreetInsider

Apr 28, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 25, 2025

CorMedix Inc. to Host Earnings Call - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 25, 2025

CorMedix Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - investchronicle.com

Apr 25, 2025
pulisher
Apr 23, 2025

Upward Trajectory: CorMedix Inc (CRMD) Posts a Gaine, Closing at 8.50 - DWinneX

Apr 23, 2025
pulisher
Apr 23, 2025

CorMedix Inc (CRMD) may enjoy gains as insiders got busy in the recent days - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

Perhaps timely catching CorMedix Inc (CRMD) would be a good idea - Sete News

Apr 23, 2025
pulisher
Apr 22, 2025

Breakeven Is Near for CorMedix Inc. (NASDAQ:CRMD) - simplywall.st

Apr 22, 2025
pulisher
Apr 22, 2025

Are CorMedix Inc’shares a good deal? - uspostnews.com

Apr 22, 2025
pulisher
Apr 22, 2025

Why Buy Stock In CorMedix Inc (CRMD)? - Marketing Sentinel

Apr 22, 2025
pulisher
Apr 22, 2025

(CRMD) On The My Stocks Page - news.stocktradersdaily.com

Apr 22, 2025

CorMedix Inc Stock (CRMD) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$65.08
price down icon 0.84%
$19.36
price down icon 0.31%
$33.15
price up icon 0.15%
$23.96
price down icon 2.80%
$92.77
price down icon 2.12%
biotechnology ONC
$231.99
price down icon 1.67%
Cap:     |  Volume (24h):